FOR IMMEDIATE RELEASE
Ambassador Mark R. Dybul Named Next Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria
Friends of the Global Fight President Deborah Derrick Praises Dr. Dybul as an “Outstanding Choice to Build on the Global Fund’s Decade of Success in the Fight for Better Health Worldwide”
Washington, D.C., November 15, 2012 — Today the Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria, the world’s largest health financier, appointed Ambassador Mark R. Dybul as the organization’s next Executive Director. Dr. Dybul previously served as the U.S. Global AIDS Coordinator and led the implementation of the President’s Emergency Plan for AIDS Relief (PEPFAR), the biggest international health program ever established for a single disease — and an integral partner to the Global Fund. Dr. Dybul is slated to assume his new position at the Global Fund in early 2013.
Deborah Derrick, President of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, applauded the Global Fund Board’s decision. “Mark Dybul is an outstanding choice to build on the Global Fund’s decade of success in the fight for better health worldwide,” said Ms. Derrick. “Dr. Dybul is a respected international leader and advocate who offers the Global Fund a wealth of experience from his time as U.S. Global AIDS Coordinator and an illustrious career in global health.”
During his tenure as U.S. Global AIDS Coordinator under President George W. Bush, Dr. Dybul managed the U.S. relationship with the Global Fund and chaired the Global Fund Board’s Finance and Audit Committee. Dr. Dybul, a physician with a specialty in infectious diseases, brings knowledge and experience from an array of health management positions. Currently the co-director of Georgetown University’s Global Health Law Center, Dr. Dybul is also widely published in scientific and health policy literature.
With strong support from the United States, the Global Fund finances health programs in 150 countries, providing prevention and treatment for HIV/AIDS, tuberculosis and malaria. Global Fund-supported programs save 100,000 lives every month, and at the prompting of the U.S. and other donors, earlier this year the Global Fund initiated a series of institutional improvements to further strengthen its work around the world. Dr. Dybul will assume leadership of the Global Fund as the organization nears the successful completion of this overhaul.
With an intensified focus on those it serves, the Global Fund has reformed its governance structure, bolstered risk management, and grown more agile all under the leadership of outgoing General Manager Gabriel Jaramillo. The secretariat reduced its staff by 20% and refocused the remaining 75% of staff onto grants management, particularly for its 20 highest-impact countries. One of the final — and most critical
— elements of the reform process, a new funding model, was approved by the Global Fund board today. This new model focuses investments more tightly in places with the greatest disease burdens and unmet needs.
According to Ms. Derrick, “the Global Fund has undertaken what is probably the most dramatic and rapid transformation of any multinational organization in history.” With a new funding model and streamlined operations, “Dr. Dybul is exceptionally well-poised to capitalize on both the Global Fund’s great work and its recent improvements.”
An innovative model, the Global Fund was founded on a commitment to accountability and transparency, for which it has been broadly recognized. For two years in a row, the Global Fund was ranked among the top five most transparent aid organizations globally.i Recent improvements further add to that legacy.
“The Global Fund’s enhanced commitment to the principles of accountability, transparency and efficiency means that it will continue to be a tremendous return on investment, with its impact measured in lives saved and communities transformed,” said Jonathan Klein, CEO and Co-Founder of Getty Images and Board Chair of Friends of the Global Fight. “Dr. Dybul’s leadership and solid track record in global health will strengthen the Global Fund’s ability to drive vital progress in the fight against HIV/AIDS, tuberculosis and malaria.”
Throughout the last decade, including during Dr. Dybul’s tenure as U.S. Global AIDS Coordinator, the United States has played a strong leadership role in global health, both through its own bilateral programs like PEPFAR and as the Global Fund’s largest donor. “With stalwart bipartisan support from Congress and the past two Administrations, U.S. investments in the Global Fund have saved lives and strengthened communities around the world,” said Ms. Derrick.
“Friends of the Global Fight has a longstanding relationship with Dr. Dybul, and we look forward to working closely with him to secure continued strong support for the Global Fund, ensuring more babies are born HIV-free, more children sleep protected from malaria under insecticide-treated nets, and more families can lead healthier, more productive lives.”
FRIENDS OF THE GLOBAL FIGHT AGAINST AIDS, TUBERCULOSIS AND MALARIA
Friends of the Global Fight works to end the worldwide burden of AIDS, tuberculosis and malaria. We educate, engage and mobilize U.S. decision makers to support the Global Fund, the world’s largest public health financier. For more information about Friends of the Global Fight, visit www.TheGlobalFight.org.
THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA
The Global Fund is an international financing institution dedicated to attracting and disbursing resources to prevent and treat HIV and AIDS, TB and malaria. The Global Fund promotes partnerships between governments, civil society, the private sector and affected communities, the most effective way to help reach those in need. This innovative approach relies on country ownership and performance-based funding, meaning that people in countries implement their own programs based on their priorities and the Global Fund provides financing where verifiable results are achieved.
Since its creation in 2002, the Global Fund has approved funding of US$ 22.9 billion for more than 1,000 programs in 151 countries. To date, programs supported by the Global Fund have provided AIDS treatment for 3.6 million people, anti-tuberculosis treatment for 9.3 million people and 270 million insecticide-treated nets for the prevention of malaria. The Global Fund works in close collaboration with other bilateral and multilateral organizations to supplement existing efforts in dealing with the three diseases.
To download PDF version click here.